Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

INDUSTRY 18 OTHER 10 NIH 1 NETWORK 1 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1 Adenocarcinoma 1

Interventions

Specimen Handling 47 Magnetic Resonance Spectroscopy 38 Cyclophosphamide 28 Vincristine 22 Radiation 19 Dexamethasone 19 Etoposide 18 Cisplatin 18 Carboplatin 17 Biopsy 17 Radiotherapy 16 Doxorubicin 13 Cytarabine 13 daratumumab 12 Leucovorin 12 Methotrexate 11 Gemcitabine 11 X-Rays 10 Standard of Care 10 Platinum 10 Docetaxel 10 durvalumab 9 Rituximab 9 Radiotherapy, Intensity-Modulated 9 Prednisone 9 Practice Guidelines as Topic 9 Calcium Dobesilate 9 1,2-diaminocyclohexaneplatinum II citrate 9 merphos 8 dexamethasone acetate 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × abiraterone × 90 days × Clear all

NCT06592924 2026-04-14

TRIPLE-SWITCH

Canadian Cancer Trials Group

Phase 3 Recruiting

Adenocarcinoma, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡